Found 23 matching trials
Developing a Whole-body MRI and Diffusion-weighted Imaging State-of-the-art Protocol: a Pilot Study
N/AWhole-body magnetic resonance imaging (WB-MRI) is a non-ionizing imaging me...
Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Radiologia
Whole Body Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) in Multiple Myeloma
NABone disease in multiple myeloma (MM) is routinely assessed by skeletal X-r...
Location
Multiple Locations
PET/MRI in Patients With Suspected Prostate Cancer
PHASE3This diagnostic clinical trial will be conducted according to a randomized,...
Location
Department of Biomedical Imaging and Image-guided Therapy
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
PHASE1This pilot phase I trial studies how well positron emission tomography (PET...
Location
M D Anderson Cancer Center
PUMA (Paediatric Osseous Marrow Assessment)
N/AThis is a pilot cancer imaging study investigating change in the apparent d...
Location
The Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Whole Body Magnetic Resonance Imaging Study
N/AIn prostate cancer bone is the most common site for cancer spread, causing ...
Location
The Royal Marsden NHS Foundation Trust
Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer
NAThe aim of this study is to assess whole body diffusion weighted imaging (W...
Location
University Hospitals UZ Leuven, Gasthuisberg
Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
NAThis study is being conducted to determine if Whole Body MRI (WBMRI) can be...
Status
Active Not Recruiting
Location
Children's National Health System
Machine Learning in Myeloma Response
NADiffusion-weighted Whole Body Magnetic Resonance Imaging (WB-MRI) is a new ...
Location
Department of Radiology, The Royal Marsden NHS Foundation Trust
Whole-Body Diffusion-Weighted Magnetic Resonance Imaging (MRI) as a Response Biomarker for Metastatic Prostate Cancer
NAThe skeleton is the most frequent organ of distal metastases in prostate ca...
Location
Vall d'Hebron Institute of Oncology